(Q79832999)
Statements
Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon alpha-2B for reducing recurrence of superficial bladder cancer (English)
Fadi N Joudi
Brian J Smith
National BCG-Interferon Phase 2 Investigator Group
1 reference
1 reference
1 reference
1 reference